首页> 外文期刊>BMC Cardiovascular Disorders >Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study
【24h】

Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study

机译:多中心前瞻性研究表明,农村女性ST段抬高急性心肌梗死再灌注治疗后肾功能不全与2年死亡率相关

获取原文
           

摘要

Renal insufficiency (RI) following ST-segment elevation acute myocardial infarction (STEMI) is associated with a worse clinical prognosis. We investigated the impact of RI on long-term mortality in rural female patients with STEMI and evaluated prognostic factors. A prospective cohort study of 436 consecutive rural female patients who were successfully treated with reperfusion therapy for STEMI between May 2009 and August 2011 in secondary care hospitals in Liaoning province northeastern China and followed up for 2?years. Patients were divided into three groups by estimated glomerular filtration rate (eGFR): Normal group, eGFR ≥90?mL/min/1.73?m2 (n?=?233). Moderate group, eGFR 60–90?mL/min/1.73?m2 (n?=?108). RI group, eGFR <60?mL/min/1.73?m2 (n?=?95). The primary outcome was 2-year mortality. During follow-up (mean 741?±?118?days), the RI group had a significantly higher mortality than the other groups (24.21?% vs. 6.87?% and 10.19?%, p?
机译:ST段抬高急性心肌梗死(STEMI)后的肾功能不全(RI)与较差的临床预后相关。我们调查了RI对农村女性STEMI患者长期死亡率的影响,并评估了预后因素。一项前瞻性队列研究对2009年5月至2011年8月间在中国东北辽宁省的二级保健医院成功接受STEMI再灌注治疗的436名农村女性患者进行了为期2年的随访。根据估计的肾小球滤过率(eGFR)将患者分为三组:正常组,eGFR≥90?mL / min / 1.73?m2(n?=?233)。中度组,eGFR 60-90?mL / min / 1.73?m2(n?=?108)。 RI组,eGFR <60?mL / min / 1.73?m2(n?=?95)。主要结局为2年死亡率。在随访期间(平均741±±118天),RI组的死亡率显着高于其他两组(24.21 %% vs. 6.87 %%和10.19 %%,p 0.001)。 RI组的住院死亡率明显高于正常组(7.37%p = 0.045)。 RI增加了医院死亡的风险(危险比(HR)1.832,95%CI 1.017-3.091,p?=?0.033),并增加了两年死亡率的风险(HR 3.872,95%CI 2.004-6.131 ,p≤0.001。多变量分析显示eGFR <90?ml / min / 1.73?m2和年龄≥75岁是2岁时死亡率的独立预测因子。具体来说,这些是eGFR 60-90?ml / min / 1.73?m2,HR 2.081,95%CI 1.250-2.842,p≤0.001。 eGFR <60?ml / min / 1.73?m2,HR 3.872,95%CI 2.004-6.131,p <0.001。年龄≥75,HR为1.461,95%CI为1.011-1.952,p?=?0.024。 RI与农村女性STEMI再灌注治疗后的长期死亡率密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号